Financial Year |
March 31 2023 |
Monetary Funds |
2,557,607,423.18 |
Held-for-trading Financial Assets |
3,915,920.00 |
Notes Receivable |
310,000.00 |
Accounts Receivable |
1,290,239,304.81 |
Advances to Suppliers |
20,430,951.72 |
Other Receivables |
24,047,650.87 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
635,081,067.72 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
27,239,787.30 |
Other Current Assets |
120,421,011.75 |
Total Current Assets |
4,734,479,594.43 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
24,733,789.53 |
Long-term Equity Investment |
55,552,648.98 |
Investment Properties |
-- |
Fixed Assetes |
751,863,063.55 |
Under-construction Projects |
10,018,084.39 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
244,006,890.48 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
7,613,979.09 |
Deferred Income Tax Assets |
55,984,182.56 |
Other Non-Current Assets |
3,435,519.37 |
Sub-Total of Non-Current Assets |
1,221,794,036.27 |
Total Assets |
5,956,273,630.70 |
Short-Term Loans |
60,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
1,358,371,834.41 |
Accounts Payable |
835,617,064.04 |
Accounts Received In Advance |
5,170,556.23 |
Employee Compensation Payable |
49,171,077.19 |
Taxes Payable |
35,844,804.28 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
68,364,737.27 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
17,602,082.87 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
2,514,620,995.48 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
46,122,395.16 |
Total Liabilities |
2,560,743,390.64 |
Paid-In Capital(Or Share Stock) |
476,944,575.00 |
Capital Surplus |
714,639,469.38 |
Surplus Reserve |
238,472,287.50 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,905,586,689.20 |
Minority Stockholder's Interest |
58,064,150.49 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,337,466,089.57 |
Owner's Equity(Stockholder's Equity) |
3,395,530,240.06 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,956,273,630.70 |